St. Clair Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$940K Buy
6,470
+222
+4% +$30.7K 0.23% 50
2026
Q2
$803K Hold
6,248
– – 0.21% 56
2026
Q1
$752K Sell
6,248
-20
-0.3% -$2.31K 0.2% 56
2025
Q4
$660K Buy
6,268
+400
+7% +$37.5K 0.17% 56
2025
Q3
$493K Buy
5,868
+20
+0.3% +$1.65K 0.13% 65
2025
Q2
$463K Hold
5,848
– – 0.12% 65
2025
Q1
$525K Hold
5,848
– – 0.15% 61
2024
Q4
$582K Buy
5,848
+462
+9% +$47.6K 0.17% 58
2024
Q3
$612K Hold
5,386
– – 0.17% 59
2024
Q2
$667K Hold
5,386
– – 0.21% 52
2024
Q1
$711K Hold
5,386
– – 0.23% 51
2023
Q4
$587K Sell
5,386
-200
-4% -$20.8K 0.2% 58
2023
Q3
$575K Hold
5,586
– – 0.23% 56
2023
Q2
$645K Buy
5,586
+1,386
+33% +$157K 0.25% 50
2023
Q1
$447K Buy
+4,200
New +$453K 0.19% 59

Other funds holding MRK

St. Clair Advisors's MRK Position: Q3 2026 in Review

St. Clair Advisors increased its Merck (MRK) stake by 3.6% in Q3 2026, buying an estimated $30.7K and bringing the position to 6,470 shares worth $940K. The position accounts for 0.23% of the portfolio, ranked #50.

St. Clair Advisors first reported a position in MRK in Q1 2023 and has held it in 15 quarters since. 1,277 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • St. Clair Advisors held 6,470 shares of Merck worth $940K as of Q3 2026.
  • St. Clair Advisors bought 222 Merck shares in Q3 2026, an estimated $30.7K.
  • Merck made up 0.23% of St. Clair Advisors's portfolio in Q3 2026, its #50 holding.
  • St. Clair Advisors first reported a position in Merck in Q1 2023 and has held it in 15 quarters since.
  • 1,277 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on St. Clair Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.